Patrick C Thornton

Suggest Changes
Learn More
BACKGROUND Sulfasalazine is well established in the treatment of active ulcerative colitis. Intolerance to sulfasalazine, however, is a common problem. Balsalazide has been designed to deliver(More)
BACKGROUND The patient-centred approach is new to the management of ulcerative colitis. To date, it has only been shown to be successful in a short-term study. AIM To assess the feasibility, safety(More)